Hy's law

被引：146

作者：

Reuben, A ^{[1
]}

机构：

[1] Med Univ S Carolina, Dept Med, Div Gastroenterol & Hepatol, Charleston, SC 29425 USA

来源：

HEPATOLOGY | 2004年 / 39卷 / 02期

关键词：

D O I：

10.1002/hep.20081

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：574 / 578

页数：5

共 41 条

[1]

Ali M, 1993, Bull Indian Inst Hist Med Hyderabad, V23, P151

[2]

*AV, 1999, CAN MED

[3]

BANG FL, 1774, SOC MED HAVN COLLECT, V1, P307

[4]

INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].

BATES, DW ;

CULLEN, DJ ;

LAIRD, N ;

PETERSEN, LA ;

SMALL, SD ;

SERVI, D ;

LAFFEL, G ;

SWEITZER, BJ ;

SHEA, BF ;

HALLISEY, R ;

VANDERVLIET, M ;

NEMESKAL, R ;

LEAPE, LL .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34

[5]

BATES DW, 1998, JAMA-J AM MED ASSOC, V279, P1200

[6]

Bernard C., 1864, REV DEUX MONDES, V53, P164

[7]

BLACK M, 1975, GASTROENTEROLOGY, V69, P289

[8]

BRYAN CP, 1931, PAPYRUS EBERS, P15

[9]

Medicinals for the millennia - The historical record [J].

Cragg, GM ;

Newman, DJ .

NEW VISTAS IN THERAPEUTICS, FROM DRUG DESIGN TO GENE THERAPY: DRUG-RESISTANT TUBERCULOSIS, FROM MOLECULES TO MACRO-ECONOMICS, 2001, 953 :3-25

[10]

DAVIDSON CS, 1979, NIH PUBLICATION

← 1 2 3 4 5 →